- Home
- JRVR vs SMTI Comparison
JRVR vs SMTI Comparison
Compare JRVR & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JRVR | SMTI |
|---|---|---|
| Founded | 2002 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.2M | 182.6M |
| IPO Year | 2014 | 2008 |
Fundamental Metrics
Financial Performance| Metric | JRVR | SMTI |
|---|---|---|
| Price | $4.13 | $23.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $7.33 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 538.7K | 37.7K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.64% | N/A |
| EPS Growth | ★ 125.82 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $687,614,000.00 | $15,586,976.00 |
| Revenue This Year | N/A | $17.31 |
| Revenue Next Year | $1.61 | $12.48 |
| P/E Ratio | ★ N/A | $464.05 |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $3.76 | $16.05 |
| 52 Week High | $7.20 | $35.70 |
Technical Indicators
Market Signals| Indicator | JRVR | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 27.71 | 70.87 |
| Support Level | $3.76 | $22.60 |
| Resistance Level | $5.61 | $24.33 |
| Average True Range (ATR) | 0.29 | 1.41 |
| MACD | -0.03 | 0.42 |
| Stochastic Oscillator | 14.40 | 88.72 |
Price Performance
Historical ComparisonAbout JRVR James River Group Holdings Ltd.
James River Group Holdings Inc is a holding company that owns and operates a group of specialty insurance companies focused on underwriting small and middle market casualty risks within the U.S. excess and surplus (E&S) lines market. The Company operates in two specialty property-casualty insurance segments: Excess and Surplus Lines and Specialty Admitted Insurance.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.